CPAP Devices Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 4.38 Billion |
| Market Size (2029) | USD 6.46 Billion |
| CAGR (2024 - 2029) | 8.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
CPAP Devices Market Analysis
The CPAP Devices Market size is estimated at USD 4.38 billion in 2024, and is expected to reach USD 6.46 billion by 2029, growing at a CAGR of 8.10% during the forecast period (2024-2029).
Factors such as the rising burden of sleep disorders and respiratory diseases, technological advancements in CPAP devices, and the increasing prevalence of obesity and hypertension are expected to boost the growth of the CPAP devices market over the forecast period.
The high incidences of sleep disorders such as sleep apnea among the population are expected to fuel the demand for CPAP devices as they deliver a steady stream of air, preventing the airway from collapsing during breathing, which reduces interruption in breathing, thus propelling market growth. For instance, according to the Global Sleep Survey 2024 report, individuals are facing disruptions in their sleep patterns in 2024 globally. Similarly, according to a study conducted in Brazil’s Sao Paulo, published in January 2024, the prevalence of obstructive sleep apnea among the Brazillian population ranged between 32.9% and 43.2% in 2022, with a higher prevalence observed in males as compared to females. Thus, the prevalence of sleep apnea raises the demand for CPAP devices, thus bolstering market growth.
Various studies have been conducted to assess the prevalence of chronic obstructive pulmonary disease (COPD) in individuals aged 40 years and older globally. For instance, according to an article published in BMC Public Health, in January 2024, the overall prevalence of COPD in people aged 40 years and older was 12.64% in 2022. The men (15.47%) had a higher prevalence of COPD compared to women (8.79%). The study demonstrated that the highest prevalence was recorded in Southeast Asian countries and the lowest prevalence was recorded in the Americas. As the number of COPD patients grows globally, the need for respiratory support rises. CPAP devices are often used to help alleviate breathing difficulties, particularly in those with moderate to severe COPD. This increases the demand for CPAP devices in both hospital and homecare settings, which is anticipated to bolster market growth over the forecast period.
Furthermore, technological advancements in CPAP devices are set to enhance their adoption, propelling market growth during the forecast period. For instance, in August 2024, Oxymed, a prominent respiratory brand in India, launched an innovative range of CPAP devices aimed at transforming sleep care. Equipped with German turbines, these devices promise exceptional durability without a steep price tag. The latest offering, the Oxymed SleepEasy Auto CPAP, is readily available through dealer networks nationwide and on major online e-commerce platforms. Building on the success of its popular i-series PAP devices, this cutting-edge device features the sophisticated FlowSens algorithm, ensuring a comfort and performance level typically reserved for international brands yet offered at a significantly reduced price. Such developments are anticipated to increase the adoption of these devices by the target population, which is expected to bolster market growth over the forecast period.
Therefore, owing to the growing burden of sleep apnea and COPD among the population, coupled with the launch of technologically advanced devices in demand, the market studied is expected to grow over the forecast period. However, due to the high cost of CPAP devices and complex regulatory and reimbursement frameworks, the market studied is likely to face some impediments over the forecast period.
CPAP Devices Market Trends
Sleep Apnea Segment Expected to Witness Significant Growth Over the Forecast Period
The sleep apnea segment is expected to witness significant growth in the CPAP devices market over the forecast period owing to the growing burden of sleep apnea among the population, the rising number of studies evaluating the potential of CPAP devices in sleep apnea, and new product launches by the key players in the market.
In France, multiple studies have evaluated the efficacy of Continuous Positive Airway Pressure (CPAP) treatment for obstructive sleep apnea (OSA). For instance, a November 2024 article published in Respiratory Medicine and Research highlighted that, when compared to the general population with undiagnosed and untreated OSA, those receiving CPAP treatment experienced lower healthcare costs in the year following treatment initiation. This underscores the importance of improving access to OSA diagnosis and treatment for the broader population.
Furthermore, the rising launches of new products by key players are expected to fuel the availability of advanced CPAP devices in the market. This, in turn, is anticipated to bolster the segment’s growth over the forecast period. For instance, in March 2024, ResMed unveiled the AirFit F40, an ultra-compact full-face mask designed for sleep apnea. This innovative mask combines the comfort of smaller models with top-notch performance. Highlighting its standout feature, the AdaptiSeal cushion, the company emphasized its 100% soft silicone material, ensuring a reliable facial seal. Additionally, the mask boasts a quick-release short tube, minimizing tube drag and facilitating easy detachment and reattachment throughout the night.
Similarly, in June 2023, Airway Management launched its Morf Nasal CPAP mask, prioritizing both comfort and sustainability. This innovative mask features a silicone-free biodegradable seal, establishing a new industry benchmark. Tailored to individual facial structures and contours, it ensures an optimal and comfortable fit. Consequently, these advancements are expected to drive greater adoption of these masks among the target population, thereby propelling the segment’s growth.
Therefore, owing to factors such as new product launches and the growing number of research studies related to CPAP devices in sleep apnea, the segment studied is anticipated to grow over the forecast period.
North America Expected to Hold a Significant Market Share Over the Forecast Period
North America is expected to witness significant growth over the forecast period owing to factors such as the growing burden of respiratory diseases and sleep disorders among the population, technological advancements in CPAP devices, and new product launches by key players in the market. In addition, the growing government initiatives to launch various sleep-related awareness programs in the region are further anticipated to drive market growth over the forecast period.
The high prevalence of sleep disorders among the population is the key factor driving the demand for CPAP devices in the region, propelling market growth. For instance, as per the Sleep Apnea data published by the National Council on Aging in May 2024, about 936 million adults worldwide are estimated to have mild to severe obstructive sleep apnea (OSA), including approximately 39 million US adults who had OSA during 2021-2022. Thus, the increasing prevalence of sleep apnea created a demand for advanced devices that prevent apnea episodes and improve sleep quality. This, in turn, is anticipated to propel the growth of CPAP devices in the market.
Additionally, there is an increase in awareness among consumers about sleep apnea or sleep disorders and supportive initiatives launched by the government in the United States, which is expected to propel the market’s growth over the forecast period. For instance, according to an article published by the Center for Disease Control and Prevention (CDC) in December 2022, the CDC awarded a three-year grant (2021-2024) for the National Healthy Sleep Awareness Project. The project would focus on expanding education and awareness of obstructive sleep apnea. Hence, the rising awareness among the people in the country with government initiatives and support would drive the demand for CPAP devices in the US market, thereby boosting the market’s growth.
Furthermore, the rising new product launches by key players are anticipated to fuel the availability of innovative CPAP devices in the market, hence bolstering market growth. For instance, in April 2024, Fisher & Paykel Healthcare Corporation Limited launched the F&P Solo Nasal mask in the United States for the treatment of obstructive sleep apnea (OSA). AutoLock technology holds the mask in place with minimal force and dynamically responds to sleep movement and CPAP-therapy pressure. It is an intuitive, innovative, and first-of-a-kind product.
Moreover, in February 2024, ResMed introduced its latest AirCurve 11 series of bilevel-positive airway pressure devices in the United States. The AirCurve 11 series employs two levels of support: inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP). Enhanced with digital technology, the AirCurve 11 aims to assist providers in effectively treating sleep apnea, ensuring patients not only begin but also remain on their therapy. Thus, the development of such advanced devices is expected to propel their adoption by patients, which, in turn, is anticipated to augment the market’s growth over the forecast period.
Therefore, owing to the high burden of sleep apnea, rising government initiatives to launch awareness programs, and new product launches by key players, the market studied is expected to grow over the forecast period.
CPAP Devices Industry Overview
The market for CPAP devices is fragmented owing to the presence of a large number of key players in the market. The key players are adopting strategic activities such as new product launches, collaborations, and agreements to retain their market position. Some of the key players in the market are ResMed, Fisher & Paykel Healthcare, Koninklijke Philips NV, Drive Devilbiss International, Nidek Co. Ltd, and BMC Medical Co. Ltd.
CPAP Devices Market Leaders
-
Fisher & Paykel Healthcare Limited
-
Koninklijke Philips NV
-
Drive Devilbiss International
-
ResMed
-
Nidek Co., Ltd
*Disclaimer: Major Players sorted in no particular order
CPAP Devices Market News
- September 2024: Fisher & Paykel unveiled its latest innovation, the F&P Solo Pillows, a nasal pillow mask featuring cutting-edge AutoFit technology and an advanced AirPillow cushion. The next-generation AirPillow cushion of the F&P Solo Pillows is designed to fit snugly around the nose, ensuring a gentle and stable seal. Its low-profile design not only sits close to the face for enhanced stability but also adapts seamlessly to the nose for an ideal fit. With this launch, Fisher & Paykel further broadened its portfolio of AutoFit technology in the market.
- March 2024: ResMed introduced the AirFit F40, an ultra-compact full-face mask tailored for sleep apnea sufferers. This mask combines the comfort of its smaller counterparts with uncompromised performance. Highlighting its features, the company emphasized the AdaptiSeal cushion, developed from 100% soft silicone, ensuring a reliable facial seal. This seal remains intact, even with movement during sleep. Additionally, the mask boasts a quick-release short tube, minimizing tube drag and facilitating easy detachment and reattachment throughout the night.
CPAP Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Burden of Sleep Disorders and Respiratory Diseases
- 4.2.2 Technological Advancements in CPAP Devices
- 4.2.3 Increasing Geriatric Population and Rise in Global Healthcare Expenditure
-
4.3 Market Restraints
- 4.3.1 High Cost of CPAP Devices
- 4.3.2 Complex Regulatory and Reimbursement Frameworks
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Product Type
- 5.1.1 CPAP Masks
- 5.1.2 CPAP Machine
- 5.1.3 CPAP Humidifiers
- 5.1.4 Other Product Types (Helmets, Accessories)
-
5.2 By Application
- 5.2.1 Sleep Apnea
- 5.2.2 Chronic Obstructive Pulmonary Disease
- 5.2.3 Other Applications (Respiratory Failures, Heart Failure, Obesity Hypoventilation Syndrome)
-
5.3 By End User
- 5.3.1 Hospitals and Clinics
- 5.3.2 Home Care Patients
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Resmed
- 6.1.2 Fisher & Paykel Healthcare Limited
- 6.1.3 Koninklijke Philips NV
- 6.1.4 Drive Devilbiss International
- 6.1.5 Hamilton Medical AG (Medin Medical Innovations GmbH)
- 6.1.6 BMC Medical Co. Ltd
- 6.1.7 Wellell America Corp. (Apex Medical Corp.)
- 6.1.8 React Health
- 6.1.9 Nidek Medical
- 6.1.10 Compumedics Limited
- 6.1.11 BPL Medical Technologies
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityCPAP Devices Industry Segmentation
As per the scope of the report, continuous positive airway pressure (CPAP) devices utilize mild air pressure to maintain open airways during sleep. These devices primarily treat sleep apnea and chronic obstructive pulmonary disease. The three variants of CPAP devices include continuous PAP (CPAP), auto-adjusting PAP (APAP), and bilevel PAP (BiPAP).
The CPAP devices market is segmented by product type, application, end user, and geography. By product type, the market is segmented into CPAP masks, CPAP machines, CPAP humidifiers, and other product types. The other product types include helmets and accessories. By application, the market is segmented into sleep apnea, chronic obstructive pulmonary disease, and other applications. The other applications segment includes respiratory failure, heart failure, and obesity hypoventilation syndrome. By end user, the market is segmented into hospitals and clinics and home care patients. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. For each segment, the market sizing and forecasts have been done on the basis of value (in USD).
| By Product Type | CPAP Masks | |
| CPAP Machine | ||
| CPAP Humidifiers | ||
| Other Product Types (Helmets, Accessories) | ||
| By Application | Sleep Apnea | |
| Chronic Obstructive Pulmonary Disease | ||
| Other Applications (Respiratory Failures, Heart Failure, Obesity Hypoventilation Syndrome) | ||
| By End User | Hospitals and Clinics | |
| Home Care Patients | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
CPAP Devices Market Research FAQs
How big is the CPAP Devices Market?
The CPAP Devices Market size is expected to reach USD 4.38 billion in 2024 and grow at a CAGR of 8.10% to reach USD 6.46 billion by 2029.
What is the current CPAP Devices Market size?
In 2024, the CPAP Devices Market size is expected to reach USD 4.38 billion.
Who are the key players in CPAP Devices Market?
Fisher & Paykel Healthcare Limited, Koninklijke Philips NV, Drive Devilbiss International, ResMed and Nidek Co., Ltd are the major companies operating in the CPAP Devices Market.
Which is the fastest growing region in CPAP Devices Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in CPAP Devices Market?
In 2024, the North America accounts for the largest market share in CPAP Devices Market.
What years does this CPAP Devices Market cover, and what was the market size in 2023?
In 2023, the CPAP Devices Market size was estimated at USD 4.03 billion. The report covers the CPAP Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the CPAP Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
CPAP Devices Industry Report
Statistics for the 2024 CPAP Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. CPAP Devices analysis includes a market forecast outlook for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
